We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Closure Medical (CLSR) fomerly Tri-Point Medical (TPMC) -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (156)10/15/1998 11:20:00 PM
From: Sr K  Respond to of 184
Could be because of J&J's comment, within their earnings release, about Dermabond's sales:

(October 13): "...DERMABOND, a topical skin adhesive for wound closure, was approved for marketing by the FDA in the third quarter and initial U.S. sales have been strong."

To: Arthur Radley who wrote (156)10/15/1998 11:44:00 PM
From: David S.  Read Replies (1) | Respond to of 184
Message 3032555

On that day, the high was 26 1/8, and the close was 23 1/4. I don't think it doubled since then. Maybe it did on the Texas stock exchange?